Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Income towards Parent Company: 2012-2016

Historic Income towards Parent Company for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2016 value amounting to -$57.3 million.

  • Tvardi Therapeutics' Income towards Parent Company fell 7.81% to -$12.4 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$65.9 million, marking a year-over-year decrease of 47.01%. This contributed to the annual value of -$57.3 million for FY2016, which is 132.00% down from last year.
  • Tvardi Therapeutics' Income towards Parent Company amounted to -$57.3 million in FY2016, which was down 132.00% from -$24.7 million recorded in FY2015.
  • In the past 5 years, Tvardi Therapeutics' Income towards Parent Company registered a high of -$4.0 million during FY2013, and its lowest value of -$57.3 million during FY2016.
  • Moreover, its 3-year median value for Income towards Parent Company was -$24.7 million (2015), whereas its average is -$33.2 million.
  • In the last 5 years, Tvardi Therapeutics' Income towards Parent Company surged by 36.80% in 2013 and then crashed by 347.77% in 2014.
  • Over the past 5 years, Tvardi Therapeutics' Income towards Parent Company (Yearly) stood at -$6.3 million in 2012, then spiked by 36.80% to -$4.0 million in 2013, then crashed by 347.77% to -$17.7 million in 2014, then slumped by 39.14% to -$24.7 million in 2015, then tumbled by 132.00% to -$57.3 million in 2016.